Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker Study of the Wee1 Inhibitor Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

NCT06369155 is registered in ClinicalTrials.gov with Joyce Liu, MD as lead sponsor.

NCT NCT06369155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker Study of the Wee1 Inhibitor Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
Lead sponsor
Joyce Liu, MD
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2025
Completion date
January 31, 2028
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uterine cancer, uterine carcinoma, uterine serous carcinoma